group critical illness - a business development perspective ip – 18 group living benefits cia...

22
Group Critical Illness - A Business Development Perspective IP – 18 Group Living Benefits CIA Meeting Nov 13 – 14, 2008 Tim Griffin, FCIA, FSA AVP Product and Business Development, Special Markets

Upload: alexander-riley

Post on 12-Jan-2016

216 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Group Critical Illness - A Business Development Perspective IP – 18 Group Living Benefits CIA Meeting Nov 13 – 14, 2008 Tim Griffin, FCIA, FSA AVP Product

Group Critical Illness

- A Business Development Perspective

IP – 18 Group Living Benefits

CIA Meeting Nov 13 – 14, 2008

Tim Griffin, FCIA, FSA

AVP Product and Business Development, Special Markets

Page 2: Group Critical Illness - A Business Development Perspective IP – 18 Group Living Benefits CIA Meeting Nov 13 – 14, 2008 Tim Griffin, FCIA, FSA AVP Product

Agenda

•Background and International Perspective

•Group and Individual Comparison

•Marketing Opportunity

•Product Details and Fine Print

•Recent Developments

•Questions?

Page 3: Group Critical Illness - A Business Development Perspective IP – 18 Group Living Benefits CIA Meeting Nov 13 – 14, 2008 Tim Griffin, FCIA, FSA AVP Product

Background

* History:• In December 1967, in South Africa, the first

heart transplant was performed by Dr. Christiaan Barnard, assisted by his brother Dr. Marius Barnard

• Dr. Marius Barnard realized that saving people’s lives could create a financial liability

• In 1983, developed the world’s first CII policy

Page 4: Group Critical Illness - A Business Development Perspective IP – 18 Group Living Benefits CIA Meeting Nov 13 – 14, 2008 Tim Griffin, FCIA, FSA AVP Product

Background

* Inception dates:• South Africa - 1983

• United Kingdom - 1985

• Australia - Late 80s

• Canada - Individual 1993

- Creditor 1997

- Group 1999

• United States - 1998

Page 5: Group Critical Illness - A Business Development Perspective IP – 18 Group Living Benefits CIA Meeting Nov 13 – 14, 2008 Tim Griffin, FCIA, FSA AVP Product

CII Market in Canada – Group

* Growth• Slow in traditional markets; steeper in Creditor

• Importance of CII is growing due to increasing odds of surviving a critical illness and employers offering the product

* Product• Group CI product generally covers fewer illnesses than

individual product – although number of conditions is growing

• Offered as mandatory and voluntary

* Great potential• Untapped market

• Interest from employers to enhance current benefit program, offer voluntary supplemental health product

Page 6: Group Critical Illness - A Business Development Perspective IP – 18 Group Living Benefits CIA Meeting Nov 13 – 14, 2008 Tim Griffin, FCIA, FSA AVP Product

CII Market in Canada – Individual

* Client Profile in Canada

Who they are What they are buying

Average age is around 40 Average annual premium is about $1,000

75% between 35 and 54 Average benefit amount is $100,000

50% are to females Coverage for about 24 conditions

Over 80% are non-smokers

A majority of sales have a return of premium featureSource: Product Innovation in Living Benefits presentation,

Munich Re, September 2005.

Page 7: Group Critical Illness - A Business Development Perspective IP – 18 Group Living Benefits CIA Meeting Nov 13 – 14, 2008 Tim Griffin, FCIA, FSA AVP Product

Market Opportunity

* Emerging awareness of critical illness incidence

* Increasing odds of surviving critical illness with medical advances

* Financial strain associated with life-threatening diseases

* Trend in individuals shouldering increasing portion of health care costs

* Prescription drugs

* Public hospitals private clinics

Page 8: Group Critical Illness - A Business Development Perspective IP – 18 Group Living Benefits CIA Meeting Nov 13 – 14, 2008 Tim Griffin, FCIA, FSA AVP Product

* 38 % of Canadian women and 44 % of men will develop cancer in their lifetime

* More than 70,000 Canadians are expected to suffer from a heart attack this year

* Over 30 % of all new breast cancer diagnoses are in women, aged 20-49

* 6,500 Canadians aged 15 – 39 diagnosed with cancer each year

Sources:- National Cancer Institute of Canada, Canadian Cancer Statistics, 2006- Heart and Stroke Foundation of Canada, 2007 - Surveillance Division, CCDPC, Public Health Agency of Canada, 2003- Globe and Mail, July 7, 2008

Market Opportunity – Incidence

Page 9: Group Critical Illness - A Business Development Perspective IP – 18 Group Living Benefits CIA Meeting Nov 13 – 14, 2008 Tim Griffin, FCIA, FSA AVP Product

Market Opportunity – Incidence

* What are your chances?

0%

10%

20%

30%

40%

50%

60%

30 35 40 45 50 55

Chance of C.I. by age 75

Chance of death by age75

Male non-smoker

Source: Munich Re

Page 10: Group Critical Illness - A Business Development Perspective IP – 18 Group Living Benefits CIA Meeting Nov 13 – 14, 2008 Tim Griffin, FCIA, FSA AVP Product

Market Opportunity – Survival

* Better odds of surviving life-threatening illness support the need for Critical Illness insurance:

• Over 80 % of heart attack victims admitted to a hospital survive

• 62 % of people who are diagnosed with cancer survive at least 5 years

Sources:- Heart and Stroke foundation of Canada, 2007 - Canadian Cancer Society, Canadian Cancer Statistics 2008

Page 11: Group Critical Illness - A Business Development Perspective IP – 18 Group Living Benefits CIA Meeting Nov 13 – 14, 2008 Tim Griffin, FCIA, FSA AVP Product

Market Opportunity – Financial

* Can patients afford to survive?• 49 % of Canadians do not have a financial plan to

deal with a critical illness

* Financial consequences can be devastating:• 54 % use money from their savings

• 18 % mortgage or sell their house / other valuables

• 7 % rely on help from their family members / relatives

Source: Ipsos-Reid News Release, June 23, 2005

Page 12: Group Critical Illness - A Business Development Perspective IP – 18 Group Living Benefits CIA Meeting Nov 13 – 14, 2008 Tim Griffin, FCIA, FSA AVP Product

Market Opportunity – Plan Sponsor

• Offer enhanced benefit program to become “employer of choice”

* Complements their existing group insurance:

• Life insurance, by providing living benefit to insured

• Disability insurance, by offering benefit based on diagnosis, not tied to ability to work

• Health insurance, by helping to pay for both medical and non-medical expenses

• Look for optional supplemental health products – without additional costs

Page 13: Group Critical Illness - A Business Development Perspective IP – 18 Group Living Benefits CIA Meeting Nov 13 – 14, 2008 Tim Griffin, FCIA, FSA AVP Product

Product - Benefit Payout

* Paid in full upon approval of claim after survival period (typically 30 days)

* Regardless of ability to work

* Whether or not medical expenses incurred

* In addition to other insurance benefits

Page 14: Group Critical Illness - A Business Development Perspective IP – 18 Group Living Benefits CIA Meeting Nov 13 – 14, 2008 Tim Griffin, FCIA, FSA AVP Product

Product - No Spending Restrictions* Can use the benefit payout for:

•Mortgage and other debt obligations

•Ongoing expenses

•Home modifications

•Medical expenses (e.g. drugs not covered by provincial health plan)

•Or any other additional expenses

Page 15: Group Critical Illness - A Business Development Perspective IP – 18 Group Living Benefits CIA Meeting Nov 13 – 14, 2008 Tim Griffin, FCIA, FSA AVP Product

Product - The Fine Print

* Survival period:

• Time period that insured has to survive after diagnosis

• Generally 30 days unless otherwise specified

* 90-day waiting period for cancer

• No coverage for cancer if diagnosed or had symptoms within 90 days following coverage effective date

• Pre-existing condition limitation

• Typically 24 /24

Page 16: Group Critical Illness - A Business Development Perspective IP – 18 Group Living Benefits CIA Meeting Nov 13 – 14, 2008 Tim Griffin, FCIA, FSA AVP Product

Product - Medical Underwriting

* Basic and Optional guaranteed issue

• Do not require evidence of insurability

• Subject to pre-existing condition limitation

* Medical information requirements are different from Group Life insurance:

• Detailed medical questionnaire

• More automatic screening requirements

• Longer average turnaround time (10 to 15 days)

• Higher decline rate on average (2 – 3 times life)

Page 17: Group Critical Illness - A Business Development Perspective IP – 18 Group Living Benefits CIA Meeting Nov 13 – 14, 2008 Tim Griffin, FCIA, FSA AVP Product

Product - Claims

* Process differs from other products:

• Claim forms specific to covered illness

• Complex adjudication process – illness definition, exclusions, pre-existing conditions, etc

• Longer turn around time than Group Life (more comparable to Disability insurance)

Page 18: Group Critical Illness - A Business Development Perspective IP – 18 Group Living Benefits CIA Meeting Nov 13 – 14, 2008 Tim Griffin, FCIA, FSA AVP Product

Product - Claims* Claims – Distribution by Cause

Source: Munich Re Group CI 2006 Survey results

70%

15%

5%

3%

3%

4% Cancer

Heart Attack

Stroke

MS

Bypass Surgery

Other

Page 19: Group Critical Illness - A Business Development Perspective IP – 18 Group Living Benefits CIA Meeting Nov 13 – 14, 2008 Tim Griffin, FCIA, FSA AVP Product

Product - Claims

* Approximately 25 % of claims are declined:

* Diagnosis predates coverage effective date

* Claim is submitted for a condition not covered

* Claim is based on a pre-existing condition

* Claim is submitted within 90-day waiting period for cancer

* Claim is does not met the Illness definition

* Non-disclosure of existing medical conditions

Page 20: Group Critical Illness - A Business Development Perspective IP – 18 Group Living Benefits CIA Meeting Nov 13 – 14, 2008 Tim Griffin, FCIA, FSA AVP Product

Group CII Success Factors

* Critical success factors

• Clarity in product design – easy to understand

• Competitive plan design and pricing

• Plan sponsor support – endorsement, communication and education

• Integrated component of group benefits package

• Increased access = better spread of risk = more affordable coverage

Page 21: Group Critical Illness - A Business Development Perspective IP – 18 Group Living Benefits CIA Meeting Nov 13 – 14, 2008 Tim Griffin, FCIA, FSA AVP Product

Current market

* More NEMs - less medical u/w

* More pull from plan sponsors

* Partial payment

* Second payment

* Portability

* Loss of Independent Existence (LOIE)

Page 22: Group Critical Illness - A Business Development Perspective IP – 18 Group Living Benefits CIA Meeting Nov 13 – 14, 2008 Tim Griffin, FCIA, FSA AVP Product

Questions

?